Anika Therapeutics, Inc. (ANIK)
NASDAQ: ANIK · Real-Time Price · USD
15.26
-0.59 (-3.72%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Anika Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 116.26 | 112.82 | 119.91 | 120.79 | 113.83 | 147.79 | Upgrade
|
| Revenue Growth (YoY) | -0.68% | -5.91% | -0.73% | 6.12% | -22.98% | 13.29% | Upgrade
|
| Cost of Revenue | 48.14 | 49.01 | 43.3 | 38.26 | 40.61 | 58.39 | Upgrade
|
| Gross Profit | 68.12 | 63.81 | 76.6 | 82.53 | 73.22 | 89.41 | Upgrade
|
| Selling, General & Admin | 53.95 | 49.09 | 55.56 | 59.93 | 51.23 | 74.1 | Upgrade
|
| Research & Development | 26.42 | 25.77 | 25.54 | 21.76 | 18.32 | 27.33 | Upgrade
|
| Operating Expenses | 80.38 | 74.86 | 81.1 | 81.69 | 69.55 | 101.42 | Upgrade
|
| Operating Income | -12.26 | -11.05 | -4.5 | 0.84 | 3.67 | -12.02 | Upgrade
|
| Interest Expense | - | - | - | - | - | -0.19 | Upgrade
|
| Interest & Investment Income | 2 | 1.74 | 2.34 | 2.31 | 0.65 | - | Upgrade
|
| EBT Excluding Unusual Items | -10.26 | -9.31 | -2.16 | 3.16 | 4.32 | -12.2 | Upgrade
|
| Merger & Restructuring Charges | - | - | -0.61 | - | - | -6.47 | Upgrade
|
| Other Unusual Items | - | - | - | - | - | 21.1 | Upgrade
|
| Pretax Income | -10.26 | -9.31 | -2.76 | 3.16 | 4.32 | 2.43 | Upgrade
|
| Income Tax Expense | 0.82 | 0.67 | 6.06 | 6.6 | 2.12 | -1.71 | Upgrade
|
| Earnings From Continuing Operations | -11.08 | -9.98 | -8.83 | -3.44 | 2.2 | 4.13 | Upgrade
|
| Earnings From Discontinued Operations | 0.01 | -0.9 | -47.56 | -79.23 | -17.06 | - | Upgrade
|
| Net Income | -11.06 | -10.88 | -56.39 | -82.67 | -14.86 | 4.13 | Upgrade
|
| Net Income to Common | -11.06 | -10.88 | -56.39 | -82.67 | -14.86 | 4.13 | Upgrade
|
| Shares Outstanding (Basic) | 14 | 14 | 15 | 15 | 15 | 14 | Upgrade
|
| Shares Outstanding (Diluted) | 14 | 14 | 15 | 15 | 15 | 15 | Upgrade
|
| Shares Change (YoY) | -3.24% | -2.60% | 0.44% | 0.65% | -0.50% | 2.90% | Upgrade
|
| EPS (Basic) | -0.78 | -0.76 | -3.83 | -5.64 | -1.02 | 0.29 | Upgrade
|
| EPS (Diluted) | -0.78 | -0.76 | -3.83 | -5.64 | -1.02 | 0.28 | Upgrade
|
| Free Cash Flow | 1.04 | 4.36 | -2.33 | -7.22 | -3.08 | 3.25 | Upgrade
|
| Free Cash Flow Per Share | 0.07 | 0.30 | -0.16 | -0.49 | -0.21 | 0.22 | Upgrade
|
| Gross Margin | 58.59% | 56.56% | 63.89% | 68.33% | 64.33% | 60.49% | Upgrade
|
| Operating Margin | -10.54% | -9.79% | -3.75% | 0.70% | 3.22% | -8.13% | Upgrade
|
| Profit Margin | -9.52% | -9.64% | -47.02% | -68.44% | -13.05% | 2.80% | Upgrade
|
| Free Cash Flow Margin | 0.89% | 3.87% | -1.94% | -5.97% | -2.70% | 2.20% | Upgrade
|
| EBITDA | -6.86 | -5.47 | 1.19 | 6.35 | 9.16 | 2.3 | Upgrade
|
| EBITDA Margin | -5.90% | -4.85% | 1.00% | 5.26% | 8.04% | 1.56% | Upgrade
|
| D&A For EBITDA | 5.4 | 5.58 | 5.69 | 5.51 | 5.49 | 14.32 | Upgrade
|
| EBIT | -12.26 | -11.05 | -4.5 | 0.84 | 3.67 | -12.02 | Upgrade
|
| EBIT Margin | -10.54% | -9.79% | -3.75% | 0.70% | 3.22% | -8.13% | Upgrade
|
| Effective Tax Rate | - | - | - | 208.97% | 49.12% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.